99%(133)132 out of 133 people found this document helpful
This preview shows page 6 - 8 out of 8 pages.
into the cells with the help of insulin to produce energy, if this does not happen the accumulation of glucose in the blood can result into a serious health problem. In type 1 DM, the body is not able to produce blood glucose and store it properly and this accumulation in the blood will result to hyperglycemia. Type 1 DM is a pathologic condition. Risk factors include family history such as genetic factors, and environmental factors such as dietary components, viral infection, pancreatic cells destroyed, and hormonal conditions. Insulin therapy is the main treatment for type 1 DM but diet and exercise are also use in managing DM. Control of DM is important in preventing the development and worsening of DM complications in patients with DM. References;Arcangelo, V. P., & Peterson, A. M. (Eds.). (2013). Pharmacotherapeutics for advanced practice: A practical approach (3rd ed.). Ambler, PA: Lippincott Williams & Wilkins.
Diabetes and Drug Treatments 7American Diabetes Association (ADA). (2016a). Statistics about diabetes. Retrieved from Centers for Disease Control and Prevention (CDC). (2015). National diabetes statistics report, 2014. Retrieved from .Centers for Disease Control and Prevention (CDC). (2011). National diabetes fact sheet, 2011. Retrieved from Dholakia S, Mittal S, Quiroga I, Gilbert J, Sharples EJ, Ploeg RJ, & Friend PJ. (2016). Pancreas transplantation: past, present, and future. American Journal of Medicine. Retrieved from Healy, S. (2014). Juvenile Diabetes and Celiac Disease. Access, 28(9), 14-15.Khardori R. (2015). Type 1 diabetes mellitus. Retrieved from Larkin ME, Barnie A, Braffett BH, Cleary PA, Diminick L, Harth J, et al. Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. (2014). Musculoskeletal complications in type 1 diabetes. Diabetes Care, 37(7), 1863–9.
Diabetes and Drug Treatments 8Matsumoto S, Tomiya M, & Sawamoto O. (2016). Current status and future of clinical islet xenotransplantation. Journal of Diabetes. Retrieved online from Rekittke NE, Ang M, Rawat D, Khatri R, & Linn T. (2016). Regenerative therapy of type 1 diabetes mellitus: from pancreas islet transplantation to mesenchymal stem cells. Stem Cells International. Retrieved from Tamborlane, W. V., Bonfig, W., & Boland, E. (2001). Recent advances in treatment of youth withType 1 diabetes: better care through technology. Diabetic Medicine, 18(11), 864-870. doi:10.1046/j.1464-5491.2001.00626.x